全文获取类型
收费全文 | 6533篇 |
免费 | 286篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 135篇 |
儿科学 | 131篇 |
妇产科学 | 280篇 |
基础医学 | 850篇 |
口腔科学 | 52篇 |
临床医学 | 629篇 |
内科学 | 1935篇 |
皮肤病学 | 63篇 |
神经病学 | 618篇 |
特种医学 | 114篇 |
外科学 | 745篇 |
综合类 | 47篇 |
一般理论 | 1篇 |
预防医学 | 267篇 |
眼科学 | 111篇 |
药学 | 514篇 |
中国医学 | 12篇 |
肿瘤学 | 366篇 |
出版年
2023年 | 35篇 |
2022年 | 176篇 |
2021年 | 303篇 |
2020年 | 95篇 |
2019年 | 140篇 |
2018年 | 153篇 |
2017年 | 105篇 |
2016年 | 124篇 |
2015年 | 147篇 |
2014年 | 238篇 |
2013年 | 278篇 |
2012年 | 482篇 |
2011年 | 483篇 |
2010年 | 260篇 |
2009年 | 214篇 |
2008年 | 393篇 |
2007年 | 461篇 |
2006年 | 469篇 |
2005年 | 444篇 |
2004年 | 426篇 |
2003年 | 420篇 |
2002年 | 369篇 |
2001年 | 60篇 |
2000年 | 44篇 |
1999年 | 52篇 |
1998年 | 43篇 |
1997年 | 52篇 |
1996年 | 47篇 |
1995年 | 17篇 |
1994年 | 27篇 |
1993年 | 15篇 |
1992年 | 24篇 |
1991年 | 22篇 |
1990年 | 27篇 |
1989年 | 28篇 |
1988年 | 26篇 |
1987年 | 11篇 |
1986年 | 15篇 |
1985年 | 12篇 |
1984年 | 11篇 |
1983年 | 11篇 |
1982年 | 10篇 |
1981年 | 10篇 |
1980年 | 7篇 |
1979年 | 7篇 |
1978年 | 7篇 |
1977年 | 9篇 |
1970年 | 8篇 |
1969年 | 8篇 |
1966年 | 7篇 |
排序方式: 共有6870条查询结果,搜索用时 15 毫秒
91.
92.
Genomewide profiling of copy‐number alteration in monoclonal gammopathy of undetermined significance 下载免费PDF全文
Aneta Mikulasova Jan Smetana Marketa Wayhelova Helena Janyskova Viera Sandecka Zuzana Kufova Martina Almasi Jiri Jarkovsky Evzen Gregora Petr Kessler Marek Wrobel Brian A. Walker Christopher P. Wardell Gareth J. Morgan Roman Hajek Petr Kuglik 《European journal of haematology》2016,97(6):568-575
Monoclonal gammopathy of undetermined significance (MGUS) is a benign condition with an approximate 1% annual risk of symptomatic plasma cell disorder development, mostly to multiple myeloma (MM). We performed genomewide screening of copy‐number alterations (CNAs) in 90 MGUS and 33 MM patients using high‐density DNA microarrays. We identified CNAs in a smaller proportion of MGUS (65.6%) than in MM (100.0%, P = 1.31 × 10?5) and showed median number of CNAs is lower in MGUS (3, range 0–22) than in MM (13, range 4–38, P = 1.82 × 10?10). In the MGUS cohort, the most frequent losses were located at 1p (5.6%), 6q (6.7%), 13q (30.0%), 14q (14.4%), 16q (8.9%), 21q (5.6%), and gains at 1q (23.3%), 2p (6.7%), 6p (13.3%), and Xq (7.8%). Hyperdiploidy was detected in 38.9% of MGUS cases, and the most frequent whole chromosome gains were 3 (25.6%), 5 (23.3%), 9 (37.8%), 15 (23.3%), and 19 (32.2%). We also identified CNAs such as 1p, 6q, 8p, 12p, 13q, 16q losses, 1q gain and hypodiploidy, which are potentially associated with an adverse prognosis in MGUS. In summary, we showed that MGUS is similar to MM in that it is a genetically heterogeneous disorder, but overall cytogenetic instability is lower than in MM, which confirms that genetic abnormalities play important role in monoclonal gammopathies. 相似文献
93.
94.
95.
Piotr Remiszewski Ewa Szczerba Piotr Kalinowski Beata Gierej Krzysztof Dudek Mariusz Grodzicki Marcin Kotulski Rafa? Paluszkiewicz Waldemar Patkowski Krzysztof Zieniewicz Marek Krawczyk 《World journal of gastroenterology : WJG》2014,20(32):11333-11339
AIM: To investigate the indications and outcomes of liver transplantation for hepatic epithelioid hemangioendothelioma (HEHE).METHODS: Between 1989 and August 2013, in the Department of General, Transplant, and Liver Surgery, Medical University of Warsaw, 1306 orthotopic liver transplantations (OLTx) were performed, including 72 retransplantations. Unresectable HEHE was an indication for OLTx in 10 patients (0.8% of primary OLTx), the mean age of the patients was 40.5 ± 13.3 years (range 23-65 years), and the male-to-female ratio was 2:8. Kaplan-Meier survival analysis in HEHE, hepatocellular carcinoma (HCC), and other OLTx recipients groups was performed. The differences in mortality were compared using the χ2 test. A P-value < 0.05 indicated statistical significance.RESULTS: No concomitant liver disease was found in any patient. There was no neoadjuvant chemotherapy or radiotherapy. Liver function test results were normal in most of the patients. The levels of alpha-fetoprotein, carcinoembryonic antigen, and carbohydrate antigen 19-9 were normal. In immunohistochemical staining, the neoplastic cells were positive for factor VIII-related antigen, CD31, and CD34, which are endothelial cell markers, and negative for cytokeratin 19, cytokeratin 7, and HepPar-1. Nine patients were alive without tumor recurrence. One patient died 2 mo after OLTx due to septic complications. No morbidity was observed. Maximum follow-up was 11.4 years, with a minimum of 1 mo. The cumulative survival rate at the end of follow-up in HEHE patients was 87.5% compared with 54.3% in the HCC group and 76.3% in the other OLTx recipients group (χ2 test = 1.784, df = 2, P = 0.409).CONCLUSION: Unresectable HEHE, without extrahepatic metastases is an excellent indication for liver transplantation. Long-term survival is very good and much better than in HCC patients and the entire group of OLTx patients. 相似文献
96.
97.
98.
99.
100.